Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor

Advances in Experimental Medicine and Biology

Volumn 507, Issue , 2002, Pages 85-92

  Wilgus, T A ^a   Parrett, M L ^a   Ross, M S ^a   Tober, K L ^a   Robertson, F M ^a   Oberyszyn, T M ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; MYELOPEROXIDASE; PROSTAGLANDIN E2; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; ISOENZYME; MESSENGER RNA; PEROXIDASE; PRIMER DNA; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DERMIS; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EDEMA; ENZYME ACTIVITY; FEMALE; INFLAMMATION; LONG TERM EXPOSURE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN INFLAMMATION; ULTRAVIOLET B RADIATION; ULTRAVIOLET RADIATION; ANIMAL; ARTICLE; ENZYMOLOGY; GENETICS; HAIRLESS MOUSE; METABOLISM; NEUTROPHIL; PHYSIOLOGY; RADIATION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN DISEASE;

ANIMALIA;

ANIMALS; BIOLOGICAL MARKERS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DNA PRIMERS; FEMALE; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INFLAMMATION; ISOENZYMES; MICE; MICE, INBRED HRS; NEUTROPHILS; PEROXIDASE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RADIATION INJURIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN DISEASES; ULTRAVIOLET RAYS;

EID: 0038107288     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0193-0_14     Document Type: Conference Paper

References (17)

1. N. Cascinelli and R. Marchesini, Increasing incidence of cutaneous melanoma, ultraviolet radiation and the clinician, Photochem Photobiol. 50:497 (1989).
2. th edition, by V. Kumar, R.S. Cotran and S.L. Robbins, eds., W.B. Saunders Co., Philadelphia (1997).
3. V.A. Ziboh and J.T. Lord, Activation of phospholipase A2 and increased release of prostaglandin precursor from skin by ultraviolet irradiation, J Invest Dermatol. 70:211 (1978).
4. J.L. Wallace, Prostaglandins, NSAIDs, and cytoprotection, Gastroenterol Clin North Am. 21:L631 (1992).
5. H.R. Hershman, Prostaglandin synthase 2. Biochem Biophys Acta. 1299:125 (1996).
6. G. Furstenberger, M. Gross, and F. Marks, Eicosanoids and multi-stage carcinogenesis in NMRI mouse skin: role of prostaglandin E1 and F in conversion (first stage of tumor promotion) and promotion (second stage of tumor promotion), Carcinogenesis. 10:91 (1989).
7. T.T. Jung, N.T. Berlinger and S.K. Juhn, Prostaglandins in squamous cell carcinomas of the head and neck. Laryngoscope. 95:307 (1985).
8. L.F. Marnet, Aspirin and the potential role of prostaglandins in colon cancer, Cancer Res. 52:5575 (1992).
9. V. E. Steele, R.C. Moon, et al., Preclinical efficacy evaluation of potential chemopreventive agents in animal carcinogenesis models: methods and results from the NCA chemoprevention Drug Development Program, J Cell Biol. Suppl. 20:32 (1994).
10. F.M. Robertson, M.L. Parrett, F.S. Joarder, M.S. Ross, H.M. Abou-Issa, G. Alshafie and R.E. Harris, Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas, Cancer Letters. 122:165 (1998).
11. S.M. Fischer, H.H. Lo, G.B. Gordon, K. Siebert, G. Kelloff, R.A. Lubet and C.J. Conti, Chemopreventative activity of celecoxib, a specific cyclooxygenase inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis, Molec Carcinogen. 25:231 (1999).
12. C. Patrono and M.J. Dunn, The clinical significance of inhibition of renal prostaglandin synthesis, Kidney Inst. 32:1 (1987).
13. B.S. Reddy, C.V. Rao and K. Seibert, Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis, Cancer Res. 56:4566 (1996).
14. M.L. Parrett, H.M. Abou-lssa, G. Alshafie, M.S. Ross, R.E. Harris and F.M. Robertson, Comparative ability of ibuprofen and N-(4-hydroxyphenyl) retinamide to inhibit development of rat mammary adenocarcinomas associated with differential inhibition of gene expression of cyclooxygenase isoforms, Anti-Cancer Res. 19:5079 (1999).
15. A.P. Pentland, W. Schoggins, G.A. Scott, K.N.M. Khan and R. Han, Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition, Carcinogenesis. 20:1939 (1999).
16. T.M. Oberyszyn, K.L. Tober, M.S. Ross and F.M. Robertson, Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation, Molec Carcinogen. 22:16 (1998).
17. M.C. Stern, I.B. Gimenez-Conti, I. Budunova, et al., Analysis of two inbred strains of mice derived from the SENCAR stock with different susceptibility to skin tumor progression, Carcinogenesis. 19:125 (1998).